NFG
ONCT

Next Financial Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Next Financial Group’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed -$1K – 2355
2016
Q4 		$1K Hold
1
– – ﹤0.01% 2329
2016
Q3 		$1K Buy
+1
New +$872 ﹤0.01% 2322

Other funds holding ONCT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Next Financial Group's ONCT Position: Q1 2017 in Review

Next Financial Group sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2017, closing a stake of 1 share — an estimated $1K sold.

Next Financial Group first reported a position in ONCT in Q3 2016 and held it in 2 quarters. The position peaked at $1K in Q4 2016. 17 funds tracked by Wall St. Rank hold ONCT as of Q1 2017.

  • Next Financial Group reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 1 Oncternal Therapeutics, Inc. Common Stock share in Q1 2017, an estimated $1K.
  • Next Financial Group first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2016 and held it in 2 quarters.
  • Next Financial Group's Oncternal Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.